George W. LeMaitre - May 3, 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Signature
/s/ Val Gertz
Stock symbol
LMAT
Transactions as of
May 3, 2023
Transactions value $
-$6,350,509
Form type
4
Date filed
5/5/2023, 04:22 PM
Previous filing
Mar 27, 2023
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Sale -$6.02M -94.9K -3.78% $63.48 2.41M May 3, 2023 Direct F1, F3
transaction LMAT Common Stock Sale -$326K -5.1K -0.21% $63.98 2.41M May 4, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.01 to $63.95. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.95 to $64.00 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 Adoption date of referenced 10b5-1(c) plan is: 11/24/2021